Cargando…

Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix

BACKGROUND AND OBJECTIVE: The currentstudy aimed at investigating the histomorphological spectrum of cervical intraepithelial and invasive lesions assessing the diagnostic significance of P16/INK4a and Ki-67 in such lesions, andcorrelatingP16/ INK4a and Ki-67 immunoexpression with histologic type an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangwaiya, Ashok, Gill, Meenu, Bairwa, Shilpa, Chaudhry, Manish, Sen, Rajeev, Prakash Kataria, Sant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322520/
https://www.ncbi.nlm.nih.gov/pubmed/30636953
_version_ 1783385622464954368
author Sangwaiya, Ashok
Gill, Meenu
Bairwa, Shilpa
Chaudhry, Manish
Sen, Rajeev
Prakash Kataria, Sant
author_facet Sangwaiya, Ashok
Gill, Meenu
Bairwa, Shilpa
Chaudhry, Manish
Sen, Rajeev
Prakash Kataria, Sant
author_sort Sangwaiya, Ashok
collection PubMed
description BACKGROUND AND OBJECTIVE: The currentstudy aimed at investigating the histomorphological spectrum of cervical intraepithelial and invasive lesions assessing the diagnostic significance of P16/INK4a and Ki-67 in such lesions, andcorrelatingP16/ INK4a and Ki-67 immunoexpression with histologic type and grade. METHODS: A total of 60 cases were selectedcomprising 10 cases withchronic cervicitis, 29 cases withcervical intraepithelial neoplasia(CIN), and 21 cases withsquamous cell carcinoma. These cases were evaluated morphologically and immunohistochemically with P16 and Ki-67. RESULTS: There was no expression of P16 and Ki-67 in 10 (100%) cases withchronic cervicitis while in CIN, it was expressed in 25 (86.20%) cases and in carcinoma it was expressed in 20 (95.23%) cases. Ki-67 was expressed in 28 (96.55%) cases withCIN and in 100% of cases withcarcinoma. CONCLUSION: Cervical carcinoma is a significant contributor to cancer-related morbidity and mortality worldwide. Identification of bio-markers in cervical neoplasia is necessary to distinguish CIN from other non-neoplastic cervical lesions to prevent under treatmentor overtreatment as the histomorphological features alone are not sufficient.Significant upregulation of P16, cyclin dependent kinase inhibitor, and Ki-67, a nuclear non-histone protein, was observed in carcinoma cervix and with the increasing severity of CINs. Correlation between grades of P16 and Ki-67 among cervical pre-neoplasia and neoplasia showed an increasing P16 expression with consistently increasing Ki-67 labelling index in the groups with theincreasing severity.
format Online
Article
Text
id pubmed-6322520
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Iranian Society of Pathology
record_format MEDLINE/PubMed
spelling pubmed-63225202019-01-11 Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix Sangwaiya, Ashok Gill, Meenu Bairwa, Shilpa Chaudhry, Manish Sen, Rajeev Prakash Kataria, Sant Iran J Pathol Original Article BACKGROUND AND OBJECTIVE: The currentstudy aimed at investigating the histomorphological spectrum of cervical intraepithelial and invasive lesions assessing the diagnostic significance of P16/INK4a and Ki-67 in such lesions, andcorrelatingP16/ INK4a and Ki-67 immunoexpression with histologic type and grade. METHODS: A total of 60 cases were selectedcomprising 10 cases withchronic cervicitis, 29 cases withcervical intraepithelial neoplasia(CIN), and 21 cases withsquamous cell carcinoma. These cases were evaluated morphologically and immunohistochemically with P16 and Ki-67. RESULTS: There was no expression of P16 and Ki-67 in 10 (100%) cases withchronic cervicitis while in CIN, it was expressed in 25 (86.20%) cases and in carcinoma it was expressed in 20 (95.23%) cases. Ki-67 was expressed in 28 (96.55%) cases withCIN and in 100% of cases withcarcinoma. CONCLUSION: Cervical carcinoma is a significant contributor to cancer-related morbidity and mortality worldwide. Identification of bio-markers in cervical neoplasia is necessary to distinguish CIN from other non-neoplastic cervical lesions to prevent under treatmentor overtreatment as the histomorphological features alone are not sufficient.Significant upregulation of P16, cyclin dependent kinase inhibitor, and Ki-67, a nuclear non-histone protein, was observed in carcinoma cervix and with the increasing severity of CINs. Correlation between grades of P16 and Ki-67 among cervical pre-neoplasia and neoplasia showed an increasing P16 expression with consistently increasing Ki-67 labelling index in the groups with theincreasing severity. Iranian Society of Pathology 2018 2018-09-12 /pmc/articles/PMC6322520/ /pubmed/30636953 Text en © 2018, IRANIAN JOURNAL OF PATHOLOGY This is an open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License, (https://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Original Article
Sangwaiya, Ashok
Gill, Meenu
Bairwa, Shilpa
Chaudhry, Manish
Sen, Rajeev
Prakash Kataria, Sant
Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
title Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
title_full Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
title_fullStr Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
title_full_unstemmed Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
title_short Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
title_sort utility of p16/ink4a and ki-67 in preneoplasticand neoplastic lesions of cervix
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322520/
https://www.ncbi.nlm.nih.gov/pubmed/30636953
work_keys_str_mv AT sangwaiyaashok utilityofp16ink4aandki67inpreneoplasticandneoplasticlesionsofcervix
AT gillmeenu utilityofp16ink4aandki67inpreneoplasticandneoplasticlesionsofcervix
AT bairwashilpa utilityofp16ink4aandki67inpreneoplasticandneoplasticlesionsofcervix
AT chaudhrymanish utilityofp16ink4aandki67inpreneoplasticandneoplasticlesionsofcervix
AT senrajeev utilityofp16ink4aandki67inpreneoplasticandneoplasticlesionsofcervix
AT prakashkatariasant utilityofp16ink4aandki67inpreneoplasticandneoplasticlesionsofcervix